Lloyds Enterprises Ltd
LLOYDSENTLloyds Enterprises Ltd's earnings have outrun its stock. EPS grew +413.5% in a year against a −1.3% price move.
The sharpest disagreement: profits are rising, but only −33% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (17 weeks in) while the P/E sits at the 58th percentile of its own 8-year range. Underneath, the last four quarters read improving — profit −55.8% year on year, and −33% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Lloyds Enterprises Ltd trades at ₹69.8, in a confirmed uptrend and 17 weeks into that stage. That is +2.2% against its own 200-day average. It sits at 67% of a 52-week range of ₹43 to ₹83. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a confirmed uptrend — week 17 of stage 2, confirmed. At ₹69.8 it trades +2.2% versus its 200-day average and sits at 67% of its 52-week range (₹43–₹83).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +1,786% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-08-21) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Lloyds Enterprises Ltd's story is not scored yet against the markers our research file set on 17 May 2026. Where it sits in its own cycle: CYCLE_BOTTOM. Still open: Promoter holding dropped 11.19pp from 73.91% to 62.72% in Sep 2025 with no exchange announcement explaining the cause. Our fortnightly research layers last read it on 27 June 2026.
Our read, 17 May 2026. PAT tripled in FY26 on Steel segment result expanding 8.6x; PE at 22nd percentile while earnings accelerate — classic compression-then-rerating setup.
From the numbers. PE contracted from a 79.8x peak in Mar 2025 to 37.6x (22nd percentile of 10-year range). The contraction is earnings-driven: FY26 PAT tripled while price did not keep pace. The pe_pb_expansion_snapshots table classifies…
From the price. Price stage 2, week 17 — above its 200-day line, relative strength falling.
From the research. PAT tripled in FY26 on Steel segment result expanding 8.6x; PE at 22nd percentile while earnings accelerate — classic compression-then-rerating setup.
🚨 Where they disagree. PE contracted from a 79.8x peak in Mar 2025 to 37.6x (22nd percentile of 10-year range). The contraction is earnings-driven: FY26 PAT tripled while price did not keep pace. The pe_pb_expansion_snapshots table classifies the stock as CYCLE_BOTTOM with GOLDEN_SETUP. PE cycle history shows three full cycles since Sep 2018, with the current phase in contraction from the Mar 2025 peak. Low reliability flag is set in the snapshot, reflecting high variance in historical PE driven by irregular earnings.
What is proven. PAT tripled in FY26 on Steel segment result expanding 8.6x; PE at 22nd percentile while earnings accelerate — classic compression-then-rerating setup.
What is not proven yet. Promoter holding dropped 11.19pp from 73.91% to 62.72% in Sep 2025 with no exchange announcement explaining the cause.
🚨 Layer 1 read, 27 June 2026 — DROP. Cheap-looking PE on a tripled FY26 PAT, but the quarterly earnings are erratic noise (a negative Dec-25 quarter) on a hugely extended trading/holding entity — bottom of the slate. The headline 'PAT +238%' sits on a trading + holding company whose quarterly EPS lurched from a 1.50 spike to negative 0.05 in Dec-25 with a flat 12-quarter direction, so there is no durable operating engine to rank up. The price has already run 18x off its trough and promoters cut 11 points of holding in a single quarter, which is why this scores lowest in the batch.
What would change Layer 1’s mind. Two consecutive quarters of clean, positive, rising operating EPS from the Steel/engineering segments (breaking the flat/erratic 12-quarter pattern) with promoters stabilizing their holding would lift this off the bottom; a second negative quarter or further promoter selling would push it to DROP.
The test written in advance. Promoter Stake Reduction — Undisclosed Rationale — Promoter Stake Reduction — Undisclosed Rationale Any further decline below 62% in shareholding filings by the next result.
The test written in advance. Concurrent Corporate Actions Execution Risk — Concurrent Corporate Actions Execution Risk by the next result.
The test written in advance. Steel Segment Margin Sustainability — Steel Segment Margin Sustainability Q1 FY27 Steel segment result vs ₹74 Cr run-rate (₹297.93 Cr / 4 quarters) by the next result.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Steel Segment Operating Leverage | HIGH | — | Steel segment result surged from ₹34.58 Cr (FY25) to ₹297.93 Cr (FY26) — 8.6x expansion on 22% revenue growth. | Any further decline below 62% in shareholding filings |
| Geomysore Gold Mine Commercialization | MEDIUM | — | 31.58% stake in India's first privately operated gold mine (post-independence); ₹950 Cr/year peak revenue disclosed; commercial… | Any further decline below 62% in shareholding filings |
Lever 1 · Operating leverage — BUILDING. Steel segment result surged from ₹34.58 Cr (FY25) to ₹297.93 Cr (FY26) — 8.6x expansion on 22% revenue growth. What proves it keeps working: Steel Segment Operating Leverage. It stops working if Any further decline below 62% in shareholding filings.
Lever 8 · Demerger or value unlock — BUILDING. 31.58% stake in India's first privately operated gold mine (post-independence); ₹950 Cr/year peak revenue disclosed; commercial production imminent. What proves it keeps working: Geomysore Gold Mine Commercialization. It stops working if Any further decline below 62% in shareholding filings.
Sources: our stock research file (17 May 2026) · quarterly results through Jun 26. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Lloyds Enterprises Ltd reported ₹563 Cr of revenue in the Jun 26 quarter, +70.1% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at 29.5% a year. The last full year, FY26, came in at ₹1,756 Cr. The last four reported quarters add to ₹1,989 Cr.
FY26 revenue came in at ₹1,756 Cr (+18.0% on the year), capping 10 years at 29.5% compound. The latest quarter (Jun 26) printed ₹563 Cr, +70.1% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +31.5% growth against the decade's 29.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +33.0% over the last 4 quarters against +32.7%/yr over the last 8 — stabilising; TTM profit −21.4% vs +25.5%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Lloyds Enterprises Ltd's operating margin is 16.0% in the Jun 26 quarter, +9.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −311.0% to 13.0%. The current quarter is running above every full year in that window.
Why this happened. The Steel segment generated ₹765.82 Cr in FY26 revenue vs ₹626.76 Cr in FY25 (+22%), yet segment result expanded 8.6x to ₹297.93 Cr. This implies non-linear margin recovery — likely driven by commodity price tailwinds and fixed-cost absorption as volumes scaled. Q4 FY26 showed consolidated EBITDA margin at 6.3% vs 5.1% in Q4 FY25 (+120 bps). Sustainability depends on steel price trajectory; reversal to FY24 segment result levels (₹34 Cr) is the primary downside.
The latest quarter's operating margin is 16.0%, +9.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −311.0%–13.0%.
Why the margin moved: operating margin went +8.9 pp year on year while gross margin went +7.1 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Lloyds Enterprises Ltd earned ₹110 Cr of net profit in the Jun 26 quarter, −55.8% year on year. Full-year FY26 profit was ₹417 Cr. That is 19.5% of the quarter's revenue. The same quarter a year earlier earned ₹249 Cr.
Jun 26 profit was ₹110 Cr, −55.8% year on year. On the full year, FY26 printed ₹417 Cr (+239.0%).
🚨 Why profit moved: revenue contributed +70.1% and the margin +9.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +42.0% vs revenue +31.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −33% of Lloyds Enterprises Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−361 Cr of operating cash against ₹417 Cr of profit. After ₹222 Cr of capital spending, ₹−583 Cr was left as free cash.
FY26: operating cash of ₹−361 Cr against reported profit of ₹417 Cr, leaving free cash of ₹−583 Cr after ₹222 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −33% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −33%: the cash cycle stretched 170 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 170 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Lloyds Enterprises Ltd's cash conversion cycle runs 170 days in FY26, up from 0 days in FY21. Capital spending ran ₹496 Cr over the last 3 years. At FY26 sales of ₹1,756 Cr each day of that cycle holds about ₹4.8 Cr, so roughly ₹818 Cr sits inside the business at any moment.
FY26: debtors at 56 days, inventory at 188 days — roughly 6.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 170 days, looser than FY21's 0.
The full loop: cash goes out to suppliers and production on day 0; stock waits 188 days to sell; customers pay about 56 days after that; and suppliers themselves are paid at 74 days — netting out to the 170-day cycle.
In money terms: at FY26 sales of ₹1,756 Cr, each day of the cycle holds about ₹4.8 Cr — so the 170-day loop keeps roughly ₹818 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹496 Cr over the last 3 fiscal years against ₹39.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹71.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Lloyds Enterprises Ltd earns a ROCE of 4% in FY26. That is up from a trough of −1% in FY16. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 23.7% net margin on 0.24× asset turns.
FY26 ROCE is 4%, recovered from a FY16 trough of −1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 23.7% net margin × 0.24× asset turns × 1.73× balance-sheet leverage ≈ 9.8% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 119% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Lloyds Enterprises Ltd carries ₹798 Cr of borrowings against ₹4,143 Cr of equity in FY26, a debt-to-equity of 0.19. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹2.0 Cr to ₹798 Cr. Capital spending ran ₹496 Cr across the last 3 of those years.
FY26: borrowings of ₹798 Cr against equity of ₹4,143 Cr — a debt-to-equity of 0.19. Operating profit covers the interest bill 2×. Over 5 years borrowings went from ₹2.0 Cr to ₹798 Cr while capital spending ran ₹496 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 119% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 11.2 points of Lloyds Enterprises Ltd over 8 quarters, the biggest move on the register. That takes promoters to 62.7% of the company. Foreign institutions moved +0.4 points over the same window, to 0.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −11.2 points over 8 quarters to 62.7%; Foreign institutions: +0.4 points over 8 quarters to 0.7%; Domestic institutions: +0.1 points over 8 quarters to 0.1%.
🚨 Why the register moved: promoters drove it (−11.2 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Lloyds Enterprises Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Lloyds Enterprises Ltd trades at 93.3× P/E, mid-range by its own standards (58th percentile). Its long-run median P/E is 73.9×, measured across 8.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Why this happened. 31.58% stake in India's first privately operated gold mine (post-independence); ₹950 Cr/year peak revenue disclosed; commercial production imminent.
Today's P/E of 93.3× is mid-range by its own standards (58th percentile), against a long-run median of 73.9× measured over 8.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +413.5% against a −1.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +62.2%/yr price move, ~+137.8%/yr came from earnings growth and ~−75.6 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 119% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 29 June 2026 price, Lloyds Enterprises Ltd was paying for profit growth of about 18.7% a year. Today the market pays 93.3× P/E, the 58th percentile of its own 8-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is the whole of what a buyer is backing.
How to hold this number: it is a reading of one day's price, taken on 29 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Lloyds Enterprises Ltd reads as mixed on its fundamental arc. Mixed — revenue growth is rising at +33.0% while profit growth is falling at −21.4% — the curves disagree, so the per-curve reads carry the story. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +18.0% | +66.6% | +345.6% | +29.5% |
| Profit | +239.0% | +83.0% | +234.2% | — |
| EPS | +413.5% | +81.1% | +185.6% | — |
| Share price | −1.3% | +33.1% | +62.2% | +40.7% |
4-Factor Sector Score
50.3/100 — rank 17 of 52 in Trading · 75% evidence confidence
Lloyds Enterprises Ltd scores 50.3 out of 100 against the 52 companies it is compared with in Trading, ranking 17. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 18.1 + 11.3 + 9.1 + 11.8 = 50.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Onix Solar Energy LtdONIXSOLAR | 70.9/100Favorable setup69% evidence | 28.9/35 Revenue 26.2% · PAT 100% · OPM change 23 pp 95% evidence | 18.3/25 ROCE 32% · OPM 30% 76% evidence | 10.3/20 P/E 24.4× · PEG — 15% evidence | 13.4/20 RS sector 68.4% · RS bench -3.5% · 1Y 49.1%12 of 12 weeks ahead 70% evidence | |
| Exact sum: 28.9 + 18.3 + 10.3 + 13.4 = 70.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Rashi Peripherals LtdRPTECH | 69.0/100Favorable setup75% evidence | LEADER | 24.9/35 Revenue 40.4% · PAT 50.2% · OPM change -0.3 pp 95% evidence | 14.7/25 ROCE 17% · OPM 3% 76% evidence | 10.7/20 P/E 17.1× · PEG — 15% evidence | 18.7/20 RS sector 51.6% · RS bench 69.1% · 1Y 176.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.9 + 14.7 + 10.7 + 18.7 = 69 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Nupur Recyclers LtdNRL | 67.9/100Favorable setup87% evidence | LEADER | 22.5/35 Revenue 40.6% · PAT 29.8% · OPM change 3.6 pp 95% evidence | 16.5/25 ROCE 15.1% · OPM 11.6% 95% evidence | 9.2/20 P/E 53.6× · PEG — 50% evidence | 19.7/20 RS sector 66.4% · RS bench 88.4% · 1Y 89.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 16.5 + 9.2 + 19.7 = 67.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Magnus Steel & Infra Ltd517320 | 67.5/100Thin evidence · provisional56% evidence | 27.8/35 Revenue 100% · PAT 100% · OPM change 1.6 pp 83% evidence | 18.5/25 ROCE 171% · OPM 21.3% 76% evidence | 9.2/20 P/E 92.5× · PEG — 15% evidence | 12.0/20 RS sector — · RS bench 46.1% · 1Y 1449.6%0 of 1 week ahead to 2026-06-28 25% evidence | |
| Exact sum: 27.8 + 18.5 + 9.2 + 12 = 67.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Vision Infra Equipment Solutions LtdVIESL | 67.3/100Thin evidence · provisional56% evidence | TURNING | 19.0/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 19.8/25 ROCE 22.6% · OPM 26% 95% evidence | 10.9/20 P/E 14.9× · PEG — 15% evidence | 17.6/20 RS sector 26.9% · RS bench 44.5% · 1Y 122.8%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 19.8 + 10.9 + 17.6 = 67.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Shankara Buildpro LtdBUILDPRO | 63.3/100Mixed-positive evidence63% evidence | BREAKING OUT | 25.6/35 Revenue 26.3% · PAT 41.9% · OPM change -0.2 pp 100% evidence | 17.3/25 ROCE 39% · OPM 3.2% 100% evidence | 10.4/20 P/E 22.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence |
| Exact sum: 25.6 + 17.3 + 10.4 + 10 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Ivalue Infosolutions LtdIVALUE | 60.4/100Mixed-positive evidence60% evidence | ASLEEP | 20.6/35 Revenue 5.4% · PAT 22.1% · OPM change 5.6 pp 95% evidence | 18.6/25 ROCE 25.4% · OPM 10% 95% evidence | 11.2/20 P/E 11.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -19.4%6 of 10 weeks ahead 0% evidence |
| Exact sum: 20.6 + 18.6 + 11.2 + 10 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Sudarshan Pharma Industries Ltd543828 | 60.3/100Mixed-positive evidence82% evidence | LEADER | 20.9/35 Revenue 32.9% · PAT 24.3% · OPM change 1.5 pp 95% evidence | 13.6/25 ROCE 15.1% · OPM 9.1% 76% evidence | 8.9/20 P/E 39.2× · PEG — 50% evidence | 16.9/20 RS sector 17.5% · RS bench 33.4% · 1Y 25.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 13.6 + 8.9 + 16.9 = 60.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Euro Pratik Sales LtdEUROPRATIK | 59.9/100Mixed-positive evidence73% evidence | ASLEEP | 15.1/35 Revenue 23.9% · PAT 29% · OPM change -8 pp 100% evidence | 19.5/25 ROCE 38.4% · OPM 26% 100% evidence | 15.3/20 P/E 29.1× · PEG 0.62 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y 4.7%6 of 10 weeks ahead 0% evidence |
| Exact sum: 15.1 + 19.5 + 15.3 + 10 = 59.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10Tembo Global Industries LtdTEMBO | 59.0/100Mixed-positive evidence80% evidence | TURNING | 22.2/35 Revenue 34% · PAT 55.7% · OPM change 5 pp 95% evidence | 18.4/25 ROCE 22.8% · OPM 16% 95% evidence | 11.3/20 P/E 10.2× · PEG — 15% evidence | 7.1/20 RS sector -17.4% · RS bench -4.5% · 1Y -10.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 18.4 + 11.3 + 7.1 = 59 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Mangalam Global Enterprise LtdMGEL | 58.7/100Mixed-positive evidence80% evidence | 25.7/35 Revenue 41.4% · PAT 100% · OPM change 0.5 pp 95% evidence | 15.8/25 ROCE 17% · OPM 1.9% 95% evidence | 11.1/20 P/E 13× · PEG — 15% evidence | 6.1/20 RS sector -14.5% · RS bench -0.2% · 1Y -3.5%6 of 7 weeks ahead to 2026-08-09 100% evidence | |
| Exact sum: 25.7 + 15.8 + 11.1 + 6.1 = 58.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -14.5% and the one-year return is -3.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Arisinfra Solutions LtdARIS | 57.6/100Mixed-positive evidence65% evidence | TURNING | 22.0/35 Revenue 45.3% · PAT 100% · OPM change 2 pp 95% evidence | 15.1/25 ROCE 15.6% · OPM 11% 95% evidence | 10.8/20 P/E 15.5× · PEG — 15% evidence | 9.7/20 RS sector — · RS bench -1.2% · 1Y -12.3%4 of 10 weeks ahead 25% evidence |
| Exact sum: 22 + 15.1 + 10.8 + 9.7 = 57.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Aayush Art and Bullion Ltd540718 | 56.4/100Thin evidence · provisional54% evidence | BREAKING OUT | 21.2/35 Revenue 100% · PAT — · OPM change 1.6 pp 35% evidence | 13.2/25 ROCE 18.9% · OPM 6% 76% evidence | 8.9/20 P/E 245× · PEG — 15% evidence | 13.1/20 RS sector -1.1% · RS bench 13.5% · 1Y 29.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 13.2 + 8.9 + 13.1 = 56.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Patel Retail LtdPATELRMART | 53.8/100Mixed-positive evidence65% evidence | ASLEEP | 18.1/35 Revenue 42.3% · PAT 59.7% · OPM change -2.2 pp 95% evidence | 14.3/25 ROCE 15.3% · OPM 6.1% 95% evidence | 10.8/20 P/E 16.9× · PEG — 15% evidence | 10.6/20 RS sector — · RS bench 2.8% · 1Y -18.4%5 of 10 weeks ahead 25% evidence |
| Exact sum: 18.1 + 14.3 + 10.8 + 10.6 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Prostarm Info Systems LtdPROSTARM | 52.0/100Mixed-positive evidence65% evidence | BASING | 17.1/35 Revenue 30.5% · PAT 19.1% · OPM change 1.4 pp 95% evidence | 16.1/25 ROCE 18% · OPM 8.5% 95% evidence | 10.5/20 P/E 22× · PEG — 15% evidence | 8.3/20 RS sector — · RS bench -12.2% · 1Y -35.5%0 of 10 weeks ahead 25% evidence |
| Exact sum: 17.1 + 16.1 + 10.5 + 8.3 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Fabtech Technologies LtdFABTECH | 50.8/100Thin evidence · provisional52% evidence | TURNING | 17.5/35 Revenue 14.2% · PAT 41% · OPM change 14.8 pp 71% evidence | 12.3/25 ROCE 13.6% · OPM 5.7% 95% evidence | 11.0/20 P/E 13.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 17.5 + 12.3 + 11 + 10 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Lloyds Enterprises Ltdthis pageLLOYDSENT | 50.3/100Mixed-positive evidence75% evidence | TURNING | 18.1/35 Revenue 33% · PAT -21.4% · OPM change 9 pp 95% evidence | 11.3/25 ROCE 3.7% · OPM 16% 76% evidence | 9.1/20 P/E 93.3× · PEG — 15% evidence | 11.8/20 RS sector -5% · RS bench 8.7% · 1Y -6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 11.3 + 9.1 + 11.8 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18BMW Ventures LtdBMW | 50.0/100Thin evidence · provisional55% evidence | 16.9/35 Revenue 18.5% · PAT 24.2% · OPM change -0.6 pp 95% evidence | 11.9/25 ROCE 12% · OPM 3.4% 76% evidence | 11.2/20 P/E 12.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -18.7%0 of 10 weeks ahead 0% evidence | |
| Exact sum: 16.9 + 11.9 + 11.2 + 10 = 50 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19SG Mart LtdSGMART | 48.9/100Mixed-negative evidence93% evidence | LEADER | 13.9/35 Revenue 10.4% · PAT 14.7% · OPM change 1.4 pp 100% evidence | 8.6/25 ROCE 10.2% · OPM 4.5% 100% evidence | 8.2/20 P/E 76.1× · PEG 1.92 65% evidence | 18.2/20 RS sector 34.9% · RS bench 51.7% · 1Y 106.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 8.6 + 8.2 + 18.2 = 48.9 · Decision use: Price leads the evidence: RS versus the benchmark is 51.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 20Bizotic Commercial Ltd543926 | 48.7/100Thin evidence · provisional58% evidence | BASING | 19.8/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 18.6/25 ROCE 26.8% · OPM 8% 76% evidence | 9.7/20 P/E 34.1× · PEG — 50% evidence | 0.6/20 RS sector -86.7% · RS bench -18.3% · 1Y -72.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 18.6 + 9.7 + 0.6 = 48.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Yogi LtdYOGI | 47.9/100Thin evidence · provisional58% evidence | 20.3/35 Revenue 97.5% · PAT 68.1% · OPM change -5.9 pp 62% evidence | 9.9/25 ROCE 12.8% · OPM 2.6% 76% evidence | 9.5/20 P/E 54.1× · PEG — 15% evidence | 8.2/20 RS sector -6.5% · RS bench -2.1% · 1Y -11.1%2 of 12 weeks ahead 70% evidence | |
| Exact sum: 20.3 + 9.9 + 9.5 + 8.2 = 47.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Shiv Aum Steels LtdSHIVAUM | 47.4/100Thin evidence · provisional55% evidence | BREAKING OUT | 16.9/35 Revenue — · PAT — · OPM change 1.3 pp 45% evidence | 11.4/25 ROCE 8% · OPM 4.7% 95% evidence | 7.2/20 P/E 66.8× · PEG — 50% evidence | 11.9/20 RS sector — · RS bench 38.3% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 16.9 + 11.4 + 7.2 + 11.9 = 47.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Dhunseri Ventures LtdDVL | 46.8/100Mixed-negative evidence87% evidence | BREAKING OUT | 12.6/35 Revenue -20% · PAT 31.7% · OPM change -12 pp 95% evidence | 9.7/25 ROCE 6.7% · OPM 39% 95% evidence | 11.9/20 P/E 5.3× · PEG — 50% evidence | 12.6/20 RS sector -7.1% · RS bench 8% · 1Y -14.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 9.7 + 11.9 + 12.6 = 46.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Adani Enterprises LtdADANIENT | 45.5/100Mixed-negative evidence93% evidence | TURNING | 14.3/35 Revenue 18.1% · PAT 4.2% · OPM change 0 pp 100% evidence | 8.5/25 ROCE 5.8% · OPM 15% 100% evidence | 7.7/20 P/E 174× · PEG 1.96 65% evidence | 15.0/20 RS sector 8.6% · RS bench 23.9% · 1Y 38.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14.3 + 8.5 + 7.7 + 15 = 45.5 · Decision use: Price leads the evidence: RS versus the benchmark is 23.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 25MMTC LtdMMTC | 44.8/100Mixed-negative evidence96% evidence | ASLEEP | 15.1/35 Revenue 0% · PAT 100% · OPM change -1270 pp 100% evidence | 8.0/25 ROCE 8.7% · OPM — 84% evidence | 15.3/20 P/E 46.1× · PEG 0.92 100% evidence | 6.4/20 RS sector -14.9% · RS bench -1.9% · 1Y -4.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 8 + 15.3 + 6.4 = 44.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 26State Trading Corporation of India LtdSTCINDIA | 42.5/100Mixed-negative evidence67% evidence | ASLEEP | 19.6/35 Revenue — · PAT 100% · OPM change -14.6 pp 67% evidence | 5.6/25 ROCE -0.9% · OPM — 80% evidence | 11.9/20 P/E 14× · PEG — 50% evidence | 5.4/20 RS sector -28.7% · RS bench -5.6% · 1Y -5.6%2 of 11 weeks ahead 70% evidence |
| Exact sum: 19.6 + 5.6 + 11.9 + 5.4 = 42.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27RRP Semiconductor LtdRRP | 41.1/100Thin evidence · provisional54% evidence | 11.4/35 Revenue -80% · PAT -80% · OPM change 3.3 pp 71% evidence | 5.4/25 ROCE -32.7% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.3/20 RS sector 65.3% · RS bench 0.8% · 1Y 66.5%0 of 1 week ahead 70% evidence | |
| Exact sum: 11.4 + 5.4 + 10 + 14.3 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Cropster Agro Ltd523105 | 40.7/100Mixed-negative evidence65% evidence | 16.0/35 Revenue 28.4% · PAT 6.5% · OPM change 2.1 pp 83% evidence | 11.3/25 ROCE 12.4% · OPM 8.7% 76% evidence | 10.1/20 P/E 31× · PEG — 15% evidence | 3.3/20 RS sector -72.7% · RS bench -62.7% · 1Y -83.2%0 of 1 week ahead to 2026-08-09 70% evidence | |
| Exact sum: 16 + 11.3 + 10.1 + 3.3 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Hexa Tradex LtdHEXATRADEX | 40.3/100Mixed-negative evidence65% evidence | BASING | 17.2/35 Revenue 0.4% · PAT 70.3% · OPM change 13.6 pp 71% evidence | 6.1/25 ROCE -0.1% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.0/20 RS sector -16.8% · RS bench -3.7% · 1Y -12.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 6.1 + 10 + 7 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30Hardwyn India LtdHARDWYN | 40.2/100Mixed-negative evidence87% evidence | ASLEEP | 13.8/35 Revenue 2.6% · PAT -8.5% · OPM change -0.2 pp 95% evidence | 12.5/25 ROCE 4.8% · OPM 13% 95% evidence | 12.1/20 P/E 50.6× · PEG — 50% evidence | 1.8/20 RS sector -38.3% · RS bench -29.5% · 1Y -3.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 13.8 + 12.5 + 12.1 + 1.8 = 40.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Blue Pearl Agriventures LtdBPAGRI | 39.8/100Mixed-negative evidence69% evidence | 20.5/35 Revenue 19.3% · PAT 59.1% · OPM change 0.3 pp 95% evidence | 6.3/25 ROCE 2.2% · OPM 3.3% 76% evidence | 8.7/20 P/E 514× · PEG — 15% evidence | 4.3/20 RS sector -33.5% · RS bench -82.5% · 1Y -91.2%1 of 12 weeks ahead 70% evidence | |
| Exact sum: 20.5 + 6.3 + 8.7 + 4.3 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Pervasive Commodities Ltd517172 | 38.3/100Thin evidence · provisional52% evidence | 12.7/35 Revenue 25.6% · PAT -8.3% · OPM change -6.1 pp 95% evidence | 5.6/25 ROCE 0% · OPM -10.2% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 12.7 + 5.6 + 10 + 10 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Riddhi Siddhi Gluco Biols Ltd524480 | 38.0/100Mixed-negative evidence82% evidence | FADING | 12.4/35 Revenue -38% · PAT 38.4% · OPM change -2.8 pp 95% evidence | 6.6/25 ROCE 2.7% · OPM -3% 76% evidence | 6.5/20 P/E 37.3× · PEG — 50% evidence | 12.5/20 RS sector 10.5% · RS bench 25.4% · 1Y 33.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 12.4 + 6.6 + 6.5 + 12.5 = 38 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 34PTC India LtdPTC | 36.6/100Mixed-negative evidence82% evidence | BASING | 11.2/35 Revenue 13.3% · PAT -43.1% · OPM change -3.9 pp 95% evidence | 12.6/25 ROCE 13.4% · OPM 3.1% 76% evidence | 9.7/20 P/E 8.8× · PEG — 50% evidence | 3.1/20 RS sector -21.6% · RS bench -9.8% · 1Y -13%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.2 + 12.6 + 9.7 + 3.1 = 36.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 35Neueon Corporation LtdNEUEON | 35.6/100Thin evidence · provisional59% evidence | ASLEEP | 9.1/35 Revenue 17.8% · PAT -80% · OPM change -1039 pp 71% evidence | 3.7/25 ROCE -40.4% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.8/20 RS sector 12.7% · RS bench -1.5% · 1Y —1 of 12 weeks ahead 70% evidence |
| Exact sum: 9.1 + 3.7 + 10 + 12.8 = 35.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Kothari Industrial Corporation LtdKOTIC | 34.2/100Adverse evidence63% evidence | BASING | 18.8/35 Revenue 75.9% · PAT -80% · OPM change -41.8 pp 71% evidence | 1.6/25 ROCE -28.9% · OPM -43% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.8/20 RS sector -58.6% · RS bench -43.5% · 1Y -77.5%0 of 9 weeks ahead 70% evidence |
| Exact sum: 18.8 + 1.6 + 10 + 3.8 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 37Shanti Overseas (India) LtdSHANTI | 32.3/100Thin evidence · provisional56% evidence | 11.2/35 Revenue -63.4% · PAT 100% · OPM change -200.5 pp 40% evidence | 4.5/25 ROCE -25.2% · OPM -216.5% 71% evidence | 13.1/20 P/E 3× · PEG — 50% evidence | 3.5/20 RS sector -60.4% · RS bench -49.7% · 1Y -47.1%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 11.2 + 4.5 + 13.1 + 3.5 = 32.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 38BN Agrochem LtdBNAGROCHEM | 32.2/100Adverse evidence77% evidence | ASLEEP | 12.9/35 Revenue 84.5% · PAT -61% · OPM change -9.4 pp 100% evidence | 4.4/25 ROCE 4.4% · OPM 2.3% 100% evidence | 9.0/20 P/E 117× · PEG — 15% evidence | 5.9/20 RS sector -16.7% · RS bench -35.6% · 1Y -46.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 12.9 + 4.4 + 9 + 5.9 = 32.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 39Uniphos Enterprises LtdUNIENTER | 30.4/100Adverse evidence69% evidence | BASING | 12.6/35 Revenue -77.1% · PAT 100% · OPM change -0.9 pp 71% evidence | 4.6/25 ROCE 0.8% · OPM — 80% evidence | 8.8/20 P/E 31.4× · PEG — 50% evidence | 4.4/20 RS sector -43.6% · RS bench -22% · 1Y -41%1 of 10 weeks ahead 70% evidence |
| Exact sum: 12.6 + 4.6 + 8.8 + 4.4 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 40Oswal Agro Mills LtdOSWALAGRO | 24.7/100Adverse evidence67% evidence | 2.8/35 Revenue -80% · PAT -80% · OPM change -21782.3 pp 95% evidence | 7.8/25 ROCE 2% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.1/20 RS sector -50.3% · RS bench -32% · 1Y -49.6%0 of 6 weeks ahead to 2026-08-16 70% evidence | |
| Exact sum: 2.8 + 7.8 + 10 + 4.1 = 24.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 41Mardia Samyoung Capillary Tubes Company LtdMSCTC | 56.9/100Thin evidence · provisional32% evidence | 20.8/35 Revenue 100% · PAT 100% · OPM change — 29% evidence | 15.2/25 ROCE 22.6% · OPM 15.3% 57% evidence | 8.6/20 P/E 687× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 74.6% · 1Y 93.7%6 of 12 weeks ahead to 2026-03-08 25% evidence | |
| Exact sum: 20.8 + 15.2 + 8.6 + 12.3 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 42Proventus Agrocom LtdPROV | 56.7/100Thin evidence · provisional48% evidence | BREAKING OUT | 19.6/35 Revenue — · PAT — · OPM change 0.2 pp 26% evidence | 12.4/25 ROCE 11.5% · OPM 1.8% 95% evidence | 13.1/20 P/E 42.8× · PEG — 50% evidence | 11.6/20 RS sector — · RS bench 26.9% · 1Y —12 of 12 weeks ahead 25% evidence |
| Exact sum: 19.6 + 12.4 + 13.1 + 11.6 = 56.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 43DC Infotech & Communication LtdDCI | 56.3/100Thin evidence · provisional35% evidence | 18.6/35 Revenue — · PAT — · OPM change 0.3 pp 24% evidence | 17.6/25 ROCE 22.9% · OPM 4.7% 76% evidence | 10.6/20 P/E 20.4× · PEG — 15% evidence | 9.5/20 RS sector — · RS bench -1.6% · 1Y — 25% evidence | |
| Exact sum: 18.6 + 17.6 + 10.6 + 9.5 = 56.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 44SK Minerals & Additives Ltd544584 | 55.8/100Thin evidence · provisional36% evidence | TURNING | 16.6/35 Revenue — · PAT — · OPM change 1.3 pp 39% evidence | 19.0/25 ROCE 26.2% · OPM 10.7% 76% evidence | 10.2/20 P/E 29.5× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 4 weeks ahead 0% evidence |
| Exact sum: 16.6 + 19 + 10.2 + 10 = 55.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 45Monika Alcobev LtdMONIKA | 54.0/100Thin evidence · provisional22% evidence | 16.4/35 Revenue — · PAT — · OPM change -2 pp 15% evidence | 17.0/25 ROCE 21% · OPM 15% 57% evidence | 10.6/20 P/E 20.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -10.9%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 16.4 + 17 + 10.6 + 10 = 54 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 46Shah Foods Ltd519031 | 53.6/100Thin evidence · provisional18% evidence | TURNING | 17.1/35 Revenue — · PAT — · OPM change -10.7 pp 7% evidence | 15.3/25 ROCE — · OPM 18% 30% evidence | 8.8/20 P/E 276× · PEG — 15% evidence | 12.4/20 RS sector — · RS bench 103.9% · 1Y —4 of 4 weeks ahead 25% evidence |
| Exact sum: 17.1 + 15.3 + 8.8 + 12.4 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 47Pramara Promotions LtdPRAMARA | 51.7/100Thin evidence · provisional47% evidence | 16.6/35 Revenue — · PAT — · OPM change -1 pp 15% evidence | 13.9/25 ROCE 15.2% · OPM 15% 71% evidence | 6.9/20 P/E 51.3× · PEG — 50% evidence | 14.3/20 RS sector 7.9% · RS bench 29% · 1Y 34.5%10 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 16.6 + 13.9 + 6.9 + 14.3 = 51.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 48Manbro Industries Ltd512595 | 50.9/100Thin evidence · provisional22% evidence | 18.3/35 Revenue — · PAT — · OPM change 32.8 pp 5% evidence | 13.1/25 ROCE — · OPM 6.6% 23% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.5/20 RS sector -17.3% · RS bench 37.2% · 1Y 62.6%12 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 18.3 + 13.1 + 10 + 9.5 = 50.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 49Le Merite Exports LtdLEMERITE | 47.2/100Thin evidence · provisional40% evidence | 18.9/35 Revenue — · PAT — · OPM change 0.9 pp 15% evidence | 9.1/25 ROCE 8.6% · OPM 2.8% 71% evidence | 9.3/20 P/E 87× · PEG — 15% evidence | 9.9/20 RS sector -9% · RS bench 15% · 1Y 28.1%2 of 12 weeks ahead to 2026-05-17 70% evidence | |
| Exact sum: 18.9 + 9.1 + 9.3 + 9.9 = 47.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 50Satani Bearings Ltd505703 | 45.2/100Thin evidence · provisional38% evidence | TURNING | 20.5/35 Revenue — · PAT 100% · OPM change — 33% evidence | 4.7/25 ROCE 1% · OPM -3.7% 76% evidence | 8.6/20 P/E 5197× · PEG — 15% evidence | 11.4/20 RS sector — · RS bench 24.9% · 1Y 176.6%1 of 11 weeks ahead 25% evidence |
| Exact sum: 20.5 + 4.7 + 8.6 + 11.4 = 45.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 51Keto Motors Ltd537392 | 43.3/100Thin evidence · provisional38% evidence | TURNING | 16.3/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.0/25 ROCE -0.3% · OPM 10.7% 76% evidence | 8.5/20 P/E 7503× · PEG — 15% evidence | 12.5/20 RS sector — · RS bench 272.8% · 1Y —4 of 4 weeks ahead 25% evidence |
| Exact sum: 16.3 + 6 + 8.5 + 12.5 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 52A-1 LtdA1L | 41.0/100Thin evidence · provisional50% evidence | 16.2/35 Revenue 8.3% · PAT -30.6% · OPM change -0.9 pp 53% evidence | 10.7/25 ROCE 10.6% · OPM 2.9% 57% evidence | 8.8/20 P/E 383× · PEG — 15% evidence | 5.3/20 RS sector -24.5% · RS bench -16% · 1Y -8.6%6 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 16.2 + 10.7 + 8.8 + 5.3 = 41 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Lloyds Enterprises Ltd's share price today?
Lloyds Enterprises Ltd trades at ₹69.8, −1.3% over the past year. The company is valued at ₹10,637 Cr. The stock sits at 67% of its 52-week range of ₹43–₹83, +2.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 17 weeks in. — as of 11 September 2026.
What were Lloyds Enterprises Ltd's latest quarterly results?
Lloyds Enterprises Ltd reported revenue of ₹563 Cr and net profit of ₹110 Cr for the Jun 26 quarter. Revenue rose 70.1% and profit fell 55.8% year on year. Earnings per share were ₹0.39. The operating margin was 16.0%, 9.0 pp higher than a year earlier. — as of 11 September 2026.
What is Lloyds Enterprises Ltd's revenue?
Lloyds Enterprises Ltd reported revenue of ₹563 Cr in the Jun 26 quarter, +70.1% year on year. For the full FY26 fiscal year, revenue was ₹1,756 Cr (+18.0%). Over the last 10 years revenue compounded at 29.5% a year. — as of 11 September 2026.
What is Lloyds Enterprises Ltd's profit?
Lloyds Enterprises Ltd earned ₹110 Cr of net profit in the Jun 26 quarter, −55.8% year on year. Full-year FY26 profit was ₹417 Cr. The operating margin ran 16.0% in the latest quarter. — as of 11 September 2026.
What is Lloyds Enterprises Ltd's market cap?
Lloyds Enterprises Ltd's market capitalisation is ₹10,637 Cr at a share price of ₹69.8. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Lloyds Enterprises Ltd's P/E ratio?
Lloyds Enterprises Ltd trades at a P/E of 93.3×, at the 58th percentile of its own 8-year range, against a long-run median of 73.9×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Lloyds Enterprises Ltd pay a dividend?
Yes — Lloyds Enterprises Ltd's dividend payout was 8% of profit in FY26, and it recorded a payout in 5 of its last 14 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Lloyds Enterprises Ltd overvalued?
On its own history, Lloyds Enterprises Ltd looks mid-range: its P/E of 93.3× sits at the 58th percentile of its 8-year range (long-run median 73.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Lloyds Enterprises Ltd growing?
Yes — Lloyds Enterprises Ltd is growing: latest-quarter revenue +70.1% year on year, profit −55.8%, and the margin +9.0 pp at 16.0%. The earnings engine currently reads: improving — as of 11 September 2026.
How is Lloyds Enterprises Ltd performing?
Lloyds Enterprises Ltd is in a confirmed uptrend, 17 weeks in. Its latest quarter's revenue rose 70.1% and profit fell 55.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Lloyds Enterprises Ltd in?
Mixed — revenue growth is rising at +33.0% while profit growth is falling at −21.4% — the curves disagree, so the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +33.0% latest, profit growth −21.4% latest, eps growth −59.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Lloyds Enterprises Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 17 of stage 2), trading +2.2% versus its 200-day average and at 67% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Lloyds Enterprises Ltd beating the market?
Not lately — on a trailing-13-week view Lloyds Enterprises Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-08-21), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +1,786% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Lloyds Enterprises Ltd's share price go up?
This page publishes no price forecast for Lloyds Enterprises Ltd. What it measures instead: the share price is ₹69.8, the price is in a confirmed uptrend 17 weeks in. Its P/E of 93.3× sits at the 58th percentile of its own 8-year range. — as of 11 September 2026.
Who owns Lloyds Enterprises Ltd?
Promoters hold 62.7% of Lloyds Enterprises Ltd, foreign institutions 0.7%, domestic institutions 0.1% and the public 36.5% (latest quarter). The biggest move on the register over the last two years: Promoters cut 11.2 points over 8 quarters. — as of 11 September 2026.
Does Lloyds Enterprises Ltd have too much debt?
No — Lloyds Enterprises Ltd's debt-to-equity is 0.19, and operating profit covers the interest bill 2×. FY26 borrowings were ₹798 Cr against equity of ₹4,143 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.
What is Lloyds Enterprises Ltd's capex?
Lloyds Enterprises Ltd spent ₹496 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹222 Cr, with ₹71.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Lloyds Enterprises Ltd's cash flow?
Lloyds Enterprises Ltd consumed ₹361 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−583 Cr). Operating cash was negative while the company reported a profit of ₹417 Cr. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Lloyds Enterprises Ltd's profit real cash?
No — operating cash was negative over the last 3 fiscal years: Lloyds Enterprises Ltd consumed cash while reporting profit. In FY26, operating cash was ₹−361 Cr against reported profit of ₹417 Cr. Cash-flow resolution is annual — as of 11 September 2026.
Where is Lloyds Enterprises Ltd in its business cycle?
Lloyds Enterprises Ltd's FY26 operating margin was 7.0%, against a 13-year band of −311.0%–13.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 16.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Lloyds Enterprises Ltd's price assume?
At its price on 29 June 2026, Lloyds Enterprises Ltd was priced for profit growth of about 18.7% a year. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Lloyds Enterprises Ltd story?
The sharpest disagreement: profits are rising, but only −33% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Lloyds Enterprises Ltd a stock worth studying right now?
This is not investment advice. The machine read: Lloyds Enterprises Ltd's earnings have outrun its stock. EPS grew +413.5% in a year against a −1.3% price move. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!